•
Apr 30, 2013

Summit Therapeutics Q1 2013 Earnings Report

Total Revenue
$392K
Previous year: $821K
-52.3%
EPS
-$0.0927
Previous year: -$0.13
-28.6%
Gross Profit
$162K
Previous year: $313K
-48.2%

Summit Therapeutics

Summit Therapeutics